Stock PHARM PHARMING GROUP N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Pharming Group N.V.

Equities

PHARM

NL0010391025

Market Closed - Euronext Amsterdam
Other stock markets
 11:35:58 2024-05-08 am EDT 		After market 03:21:47 pm
0.879 EUR -1.79% Intraday chart for Pharming Group N.V. 0.886 +0.80%
01:30pm Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024
07:00am Pharming Group N.V. Provides Revenue Guidance for 2024 CI

Evolution of the average Target Price on Pharming Group N.V.

Price target over the last 5 years

History of analyst recommendation changes

2601cc49ca9255301c74a89.FrfcIjVpo-qDTb6SAUFFtbOn-ltOsTlCFLWVxoQhFq8.c--LG1ww7djEDIbCVxQOzIXJnRMfiFcQUvfa889gQsFj3e0aTSGXsLca3Q~e58972680b3864ffb07a6ef495ceaab1

Analyst Recommendations on Pharming Group N.V.

RBC Raises Price Target on Pharming Group to EUR2.10 From EUR1.95, Keeps Outperform Rating MT
Oppenheimer Adjusts Pharming Group Price Target to $40 From $36, Maintains Outperform Rating MT
Oppenheimer Adjusts Pharming Group's Price Target to $36 From $43, Maintains Outperform Rating MT
Van Leeuwenhoeck issues research note on Pharming (PHAR.AS): Turning the Page PU
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.895 EUR
Average target price
2 EUR
Spread / Average Target
+123.46%
High Price Target
2.1 EUR
Spread / Highest target
+134.64%
Low Price Target
1.85 EUR
Spread / Lowest Target
+106.70%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Pharming Group N.V.

RBC Capital Markets
Oppenheimer

Ratings for Pharming Group N.V.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PHARM Stock
  4. Consensus Pharming Group N.V.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW